High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes


Autoria(s): Lopes-Virella, Maria F; Baker, Nathaniel L; Hunt, Kelly J; Lyons, Timothy J; Jenkins, Alicia J; Virella, Gabriel; DCCT/EDIC Study Group
Data(s)

01/06/2012

Resumo

To determine whether immunocomplexes (ICs) containing advanced glycation end product (AGE)-LDL (AGE-LDL) and oxidized LDL (oxLDL) contribute to the development of retinopathy over a 16-year period in subjects with type 1 diabetes.

Identificador

http://pure.qub.ac.uk/portal/en/publications/high-concentrations-of-ageldl-and-oxidized-ldl-in-circulating-immune-complexes-are-associated-with-progression-of-retinopathy-in-type-1-diabetes(a646437c-08b0-4f74-aa48-27646804964a).html

http://dx.doi.org/10.2337/dc11-2040

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Lopes-Virella , M F , Baker , N L , Hunt , K J , Lyons , T J , Jenkins , A J , Virella , G & DCCT/EDIC Study Group 2012 , ' High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes ' Diabetes Care , vol 35 , no. 6 , pp. 1333-40 . DOI: 10.2337/dc11-2040

Palavras-Chave #Adult #Albuminuria #Biological Markers #Cholesterol, LDL #Diabetes Mellitus, Type 1 #Diabetic Retinopathy #Disease Progression #Female #Glycosylation End Products, Advanced #Hemoglobin A, Glycosylated #Humans #Lipoproteins, LDL #Male #Proportional Hazards Models #Risk Factors
Tipo

article